Matthew C Kapusta
CIK 1536290 · CEO, Managing Director · last filed 2026-07-07
Matthew C Kapusta is a CEO, Managing Director who has filed 92 SEC Form 4 insider transactions across 3 companies since 2012. The most recent filing, for QURE, was dated Jul 7, 2026. Across all open-market trades the lifetime net is −$50.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $20.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$20.62M
3
92
-$50.17M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| QURE | CEO, Managing Director | 519,227 | $39.71 | $20.62M | -$50.18M | 69 | 2026-07-07 |
| Decibel Therapeutics, Inc. (DBTX) Delisted | Director | 0 | $4.91 | $0 | $0 | 2 | 2023-09-25 |
| ANGIODYNAMICS INC (ANGO.V) Delisted | SVP, Business Development | 30,062 | — | — | $11.4K | 11 | 2014-11-19 |
Recent Filings
92 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-07 | QURE | Mixed | — | -$543.3K | EDGAR |
| 2026-07-02 | QURE | Notice (144) | −21,082 | -$951.9K | EDGAR |
| 2026-06-26 | QURE | Mixed | −2,568 | -$729.7K | EDGAR |
| 2026-06-25 | QURE | Notice (144) | −28,716 | -$1.44M | EDGAR |
| 2026-06-24 | QURE | Notice (144) | −6,696 | -$334.8K | EDGAR |
| 2026-06-22 | QURE | Mixed | −138,863 | -$8.01M | EDGAR |
| 2026-06-18 | QURE | Notice (144) | −41,671 | -$1.93M | EDGAR |
| 2026-06-17 | QURE | Notice (144) | −164,429 | -$7.07M | EDGAR |
| 2026-03-06 | QURE | Mixed | +56,019 | -$132.1K | EDGAR |
| 2026-03-04 | QURE | Notice (144) | −14,581 | -$132.2K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.